490 related articles for article (PubMed ID: 15054093)
21. Pharmacological and signaling analysis of human chemokine receptor CCR-7 stably expressed in HEK-293 cells: high-affinity binding of recombinant ligands MIP-3beta and SLC stimulates multiple signaling cascades.
Sullivan SK; McGrath DA; Grigoriadis D; Bacon KB
Biochem Biophys Res Commun; 1999 Oct; 263(3):685-90. PubMed ID: 10512740
[TBL] [Abstract][Full Text] [Related]
22. Opposite fate of endocytosed CCR7 and its ligands: recycling versus degradation.
Otero C; Groettrup M; Legler DF
J Immunol; 2006 Aug; 177(4):2314-23. PubMed ID: 16887992
[TBL] [Abstract][Full Text] [Related]
23. Differential CCR7 Targeting in Dendritic Cells by Three Naturally Occurring CC-Chemokines.
Hjortø GM; Larsen O; Steen A; Daugvilaite V; Berg C; Fares S; Hansen M; Ali S; Rosenkilde MM
Front Immunol; 2016; 7():568. PubMed ID: 28018341
[TBL] [Abstract][Full Text] [Related]
24. beta-Arrestin 2 expression determines the transcriptional response to lysophosphatidic acid stimulation in murine embryo fibroblasts.
Gesty-Palmer D; El Shewy H; Kohout TA; Luttrell LM
J Biol Chem; 2005 Sep; 280(37):32157-67. PubMed ID: 16027114
[TBL] [Abstract][Full Text] [Related]
25. CCR7/CCL19 controls expression of EDG-1 in T cells.
Shannon LA; McBurney TM; Wells MA; Roth ME; Calloway PA; Bill CA; Islam S; Vines CM
J Biol Chem; 2012 Apr; 287(15):11656-64. PubMed ID: 22334704
[TBL] [Abstract][Full Text] [Related]
26. Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7.
Yoshida R; Nagira M; Kitaura M; Imagawa N; Imai T; Yoshie O
J Biol Chem; 1998 Mar; 273(12):7118-22. PubMed ID: 9507024
[TBL] [Abstract][Full Text] [Related]
27. Selective Boosting of CCR7-Acting Chemokines; Short Peptides Boost Chemokines with Short Basic Tails, Longer Peptides Boost Chemokines with Long Basic Tails.
Brandum EP; Jørgensen AS; Calvo MB; Spiess K; Peterson FC; Yang Z; Volkman BF; Veldkamp CT; Rosenkilde MM; Goth CK; Hjortø GM
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163323
[TBL] [Abstract][Full Text] [Related]
28. Expression of CCR7 and its ligands CCL19/CCL21 in muscles of polymyositis.
Tateyama M; Fujihara K; Misu T; Feng J; Onodera Y; Itoyama Y
J Neurol Sci; 2006 Nov; 249(2):158-65. PubMed ID: 16887149
[TBL] [Abstract][Full Text] [Related]
29. The glucagon-like peptide-2 receptor C terminus modulates beta-arrestin-2 association but is dispensable for ligand-induced desensitization, endocytosis, and G-protein-dependent effector activation.
Estall JL; Koehler JA; Yusta B; Drucker DJ
J Biol Chem; 2005 Jun; 280(23):22124-34. PubMed ID: 15817468
[TBL] [Abstract][Full Text] [Related]
30. Arrestin Recruitment to C-C Chemokine Receptor 5: Potent C-C Chemokine Ligand 5 Analogs Reveal Differences in Dependence on Receptor Phosphorylation and Isoform-Specific Recruitment Bias.
Martins E; Brodier H; Rossitto-Borlat I; Ilgaz I; Villard M; Hartley O
Mol Pharmacol; 2020 Nov; 98(5):599-611. PubMed ID: 32943494
[TBL] [Abstract][Full Text] [Related]
31. Increased levels of CCR7 ligands in carotid atherosclerosis: different effects in macrophages and smooth muscle cells.
Halvorsen B; Dahl TB; Smedbakken LM; Singh A; Michelsen AE; Skjelland M; Krohg-Sørensen K; Russell D; Höpken UE; Lipp M; Damås JK; Holm S; Yndestad A; Biessen EA; Aukrust P
Cardiovasc Res; 2014 Apr; 102(1):148-56. PubMed ID: 24518141
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of CCL19 by DC-Lamp+ mature dendritic cells in human lymph node versus chronically inflamed skin.
Katou F; Ohtani H; Nakayama T; Nagura H; Yoshie O; Motegi K
J Pathol; 2003 Jan; 199(1):98-106. PubMed ID: 12474232
[TBL] [Abstract][Full Text] [Related]
33. GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells.
Quoyer J; Longuet C; Broca C; Linck N; Costes S; Varin E; Bockaert J; Bertrand G; Dalle S
J Biol Chem; 2010 Jan; 285(3):1989-2002. PubMed ID: 19915011
[TBL] [Abstract][Full Text] [Related]
34. Constitutive ERK1/2 activation by a chimeric neurokinin 1 receptor-beta-arrestin1 fusion protein. Probing the composition and function of the G protein-coupled receptor "signalsome".
Jafri F; El-Shewy HM; Lee MH; Kelly M; Luttrell DK; Luttrell LM
J Biol Chem; 2006 Jul; 281(28):19346-57. PubMed ID: 16670094
[TBL] [Abstract][Full Text] [Related]
35. Role of the G protein-coupled receptor kinase site serine cluster in beta2-adrenergic receptor internalization, desensitization, and beta-arrestin translocation.
Vaughan DJ; Millman EE; Godines V; Friedman J; Tran TM; Dai W; Knoll BJ; Clark RB; Moore RH
J Biol Chem; 2006 Mar; 281(11):7684-92. PubMed ID: 16407241
[TBL] [Abstract][Full Text] [Related]
36. The chemokine receptor CCX-CKR mediates effective scavenging of CCL19 in vitro.
Comerford I; Milasta S; Morrow V; Milligan G; Nibbs R
Eur J Immunol; 2006 Jul; 36(7):1904-16. PubMed ID: 16791897
[TBL] [Abstract][Full Text] [Related]
37. Phosphorylation of C3a receptor at multiple sites mediates desensitization, β-arrestin-2 recruitment and inhibition of NF-κB activity in mast cells.
Gupta K; Subramanian H; Klos A; Ali H
PLoS One; 2012; 7(10):e46369. PubMed ID: 23077507
[TBL] [Abstract][Full Text] [Related]
38. CCL19 with CCL21-tail displays enhanced glycosaminoglycan binding with retained chemotactic potency in dendritic cells.
Jørgensen AS; Adogamhe PE; Laufer JM; Legler DF; Veldkamp CT; Rosenkilde MM; Hjortø GM
J Leukoc Biol; 2018 Aug; 104(2):401-411. PubMed ID: 29768676
[TBL] [Abstract][Full Text] [Related]
39. Differential ligand-signaling network of CCL19/CCL21-CCR7 system.
Raju R; Gadakh S; Gopal P; George B; Advani J; Soman S; Prasad TS; Girijadevi R
Database (Oxford); 2015; 2015():. PubMed ID: 26504105
[TBL] [Abstract][Full Text] [Related]
40. CCR7-mediated physiological lymphocyte homing involves activation of a tyrosine kinase pathway.
Stein JV; Soriano SF; M'rini C; Nombela-Arrieta C; de Buitrago GG; Rodríguez-Frade JM; Mellado M; Girard JP; Martínez-A C
Blood; 2003 Jan; 101(1):38-44. PubMed ID: 12393730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]